Summary
The global Oncology Generic Injectable Drugs Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Overview:
Injectable drug delivery is a process of introducing a drug or combination of drugs into the bloodstream of a patient by using various delivery devices such as needles and syringes. Oncology generic injectable drugs are used to treat various types of cancer such as bronchus, lung, melanoma, colorectal, prostate, and breast. These injectable drugs are available at low prices and therefore, are widely preferred over branded drugs. However, manufacturers have to follow the FDA regulations to develop these injectable drugs, which are equivalent to that of branded counterparts.
The global oncology generic injectable drugs market is divided into six regions, such as North America, South America, Asia Pacific, Europe, Middle East, and Africa.
Drivers:
Rising prevalence of chronic diseases, such as cancer and diabetes, and increasing number of cancer cases worldwide are expected to propel the global oncology generic injectable drugs market growth during the forecast period. Around 14.1 million cancer cases were accounted worldwide in 2012, and the number is expected to reach 24 million by 2035, according to the World Cancer Research Fund International. Increasing demand for self-injection devices is also expected to fuel market growth. Moreover, technological advances and new product launches are expected to drive the global oncology generic injectable drugs market growth.
Restraint:
High quality and care required during manufacturing, stringent regulations, and challenges in storage, packaging, and distribution are expected to hamper the global oncology generic injectable drugs market growth.
Opportunities:
Increasing demand for a biosimilar (drug type) and generic injectables is expected to create significant growth opportunities for the market.
Regional Insights:
North America is expected to witness robust growth in the global oncology generic injectable drugs market due to increasing incidence of chronic diseases, increasing demand for self-injection devices, and new product launches in the United States. For instance, in September 2019, Mylan launched Fulvestrant Injection, a generic version of AstraZeneca's Faslodex Injection, for the treatment of advanced breast cancer in the U.S.
Asia Pacific is also expected to witness substantial growth in the market due to increasing demand for advanced oncology treatment and increasing investments by pharmaceutical manufacturers in the region. For instance, in July 2017, Alembic Pharmaceutical inaugurated an Anti-Cancer manufacturing facility in India to manufacture generic oncology products.
Competitive Section:
- Key players operating in the global oncology generic injectable drugs market are Natco Pharma, Mylan, Novartis, GlaxoSmithKline, Eli Lilly, Roche, AstraZeneca, Pfizer, and Teva Pharmaceutical.
- In October 2020, BDR Pharmaceuticals launched the generic version of Lenvatinib drug for the treatment of various types of cancers in India.
- In September 2019, Mylan launched Fulvestrant Injection, a generic version of AstraZeneca's Faslodex Injection, for the treatment of advanced breast cancer.
- In November 2017, Mylan launched Clofarabine Injection, a generic version of Genzyme's Clolar, for the treatment of refractory acute lymphoblastic leukemia.
- In 2017, Baxter teamed up with ScinoPharm to develop, manufacture, and commercialize five injectable generic drugs for oncology and chemotherapy-related indications.
The Oncology Generic Injectable Drugs Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Oncology Generic Injectable Drugs Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Teva Pharmaceutical
- Pfizer
- AstraZeneca
- Roche
- Eli Lilly
- GlaxoSmithKline
- Novartis
- Mylan
- Natco Pharma
By the Product Type, the market is primarily segmented into:
- Large Molecule Drugs
- Small Molecule Drugs
By Applications, the market is segmented into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Oncology Generic Injectable Drugs Market Report:
- To assess the size of the market by value and volume
- Analyze the Oncology Generic Injectable Drugs Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Oncology Generic Injectable Drugs Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Oncology Generic Injectable Drugs Market
The Oncology Generic Injectable Drugs Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Oncology Generic Injectable Drugs Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
Executive Summary
1 Oncology Generic Injectable Drugs Market Overview
1.1 Product Overview and Scope of Oncology Generic Injectable Drugs
1.2 Oncology Generic Injectable Drugs Segment by Type
1.2.1 Global Oncology Generic Injectable Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Large Molecule Drugs
1.2.3 Small Molecule Drugs
1.3 Oncology Generic Injectable Drugs Segment by Application
1.3.1 Oncology Generic Injectable Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Oncology Generic Injectable Drugs Market by Region
1.4.1 Global Oncology Generic Injectable Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Oncology Generic Injectable Drugs Market Size
1.5.1 Global Oncology Generic Injectable Drugs Revenue (2014-2025)
1.5.2 Global Oncology Generic Injectable Drugs Production (2014-2025)
2 Global Oncology Generic Injectable Drugs Market Competition by Manufacturers
2.1 Global Oncology Generic Injectable Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Oncology Generic Injectable Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Oncology Generic Injectable Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Oncology Generic Injectable Drugs Production Sites, Area Served, Product Types
2.5 Oncology Generic Injectable Drugs Market Competitive Situation and Trends
2.5.1 Oncology Generic Injectable Drugs Market Concentration Rate
2.5.2 Oncology Generic Injectable Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Oncology Generic Injectable Drugs Production Market Share by Regions
3.1 Global Oncology Generic Injectable Drugs Production Market Share by Regions
3.2 Global Oncology Generic Injectable Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Oncology Generic Injectable Drugs Production
3.4.1 North America Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
3.4.2 North America Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Oncology Generic Injectable Drugs Production
3.5.1 Europe Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Oncology Generic Injectable Drugs Production (2014-2019)
3.6.1 China Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
3.6.2 China Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Oncology Generic Injectable Drugs Production (2014-2019)
3.7.1 Japan Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Oncology Generic Injectable Drugs Consumption by Regions
4.1 Global Oncology Generic Injectable Drugs Consumption by Regions
4.2 North America Oncology Generic Injectable Drugs Consumption (2014-2019)
4.3 Europe Oncology Generic Injectable Drugs Consumption (2014-2019)
4.4 China Oncology Generic Injectable Drugs Consumption (2014-2019)
4.5 Japan Oncology Generic Injectable Drugs Consumption (2014-2019)
5 Global Oncology Generic Injectable Drugs Production, Revenue, Price Trend by Type
5.1 Global Oncology Generic Injectable Drugs Production Market Share by Type (2014-2019)
5.2 Global Oncology Generic Injectable Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Oncology Generic Injectable Drugs Price by Type (2014-2019)
5.4 Global Oncology Generic Injectable Drugs Production Growth by Type (2014-2019)
6 Global Oncology Generic Injectable Drugs Market Analysis by Applications
6.1 Global Oncology Generic Injectable Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Oncology Generic Injectable Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Oncology Generic Injectable Drugs Business
7.1 Teva Pharmaceutical
7.1.1 Teva Pharmaceutical Oncology Generic Injectable Drugs Production Sites and Area Served
7.1.2 Oncology Generic Injectable Drugs Product Introduction, Application and Specification
7.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Pfizer
7.2.1 Pfizer Oncology Generic Injectable Drugs Production Sites and Area Served
7.2.2 Oncology Generic Injectable Drugs Product Introduction, Application and Specification
7.2.3 Pfizer Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 AstraZeneca
7.3.1 AstraZeneca Oncology Generic Injectable Drugs Production Sites and Area Served
7.3.2 Oncology Generic Injectable Drugs Product Introduction, Application and Specification
7.3.3 AstraZeneca Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Roche
7.4.1 Roche Oncology Generic Injectable Drugs Production Sites and Area Served
7.4.2 Oncology Generic Injectable Drugs Product Introduction, Application and Specification
7.4.3 Roche Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Eli Lilly
7.5.1 Eli Lilly Oncology Generic Injectable Drugs Production Sites and Area Served
7.5.2 Oncology Generic Injectable Drugs Product Introduction, Application and Specification
7.5.3 Eli Lilly Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Oncology Generic Injectable Drugs Production Sites and Area Served
7.6.2 Oncology Generic Injectable Drugs Product Introduction, Application and Specification
7.6.3 GlaxoSmithKline Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Novartis
7.7.1 Novartis Oncology Generic Injectable Drugs Production Sites and Area Served
7.7.2 Oncology Generic Injectable Drugs Product Introduction, Application and Specification
7.7.3 Novartis Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Mylan
7.8.1 Mylan Oncology Generic Injectable Drugs Production Sites and Area Served
7.8.2 Oncology Generic Injectable Drugs Product Introduction, Application and Specification
7.8.3 Mylan Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Natco Pharma
7.9.1 Natco Pharma Oncology Generic Injectable Drugs Production Sites and Area Served
7.9.2 Oncology Generic Injectable Drugs Product Introduction, Application and Specification
7.9.3 Natco Pharma Oncology Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
8 Oncology Generic Injectable Drugs Manufacturing Cost Analysis
8.1 Oncology Generic Injectable Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Oncology Generic Injectable Drugs
8.4 Oncology Generic Injectable Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Oncology Generic Injectable Drugs Distributors List
9.3 Oncology Generic Injectable Drugs Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors
11 Global Oncology Generic Injectable Drugs Market Forecast
11.1 Global Oncology Generic Injectable Drugs Production, Revenue Forecast
11.1.1 Global Oncology Generic Injectable Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Oncology Generic Injectable Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Oncology Generic Injectable Drugs Price and Trend Forecast (2019-2025)
11.2 Global Oncology Generic Injectable Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Oncology Generic Injectable Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Oncology Generic Injectable Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Oncology Generic Injectable Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Oncology Generic Injectable Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Oncology Generic Injectable Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Oncology Generic Injectable Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Oncology Generic Injectable Drugs Consumption Forecast (2019-2025)
11.3.3 China Oncology Generic Injectable Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Oncology Generic Injectable Drugs Consumption Forecast (2019-2025)
11.4 Global Oncology Generic Injectable Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Oncology Generic Injectable Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Table
List of Tables and Figures
Figure Picture of Oncology Generic Injectable Drugs
Table Global Oncology Generic Injectable Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Oncology Generic Injectable Drugs Production Market Share by Types in 2018
Figure Large Molecule Drugs Product Picture
Table Large Molecule Drugs Major Manufacturers
Figure Small Molecule Drugs Product Picture
Table Small Molecule Drugs Major Manufacturers
Table Global Oncology Generic Injectable Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Oncology Generic Injectable Drugs Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Table Oncology Generic Injectable Drugs Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Oncology Generic Injectable Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Oncology Generic Injectable Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Oncology Generic Injectable Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Oncology Generic Injectable Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Oncology Generic Injectable Drugs Revenue (Million USD) (2014-2025)
Figure Global Oncology Generic Injectable Drugs Production (K Units) (2014-2025)
Table Global Oncology Generic Injectable Drugs Production (K Units) of Key Manufacturers (2014-2019)
Table Global Oncology Generic Injectable Drugs Production Share by Manufacturers (2014-2019)
Figure Oncology Generic Injectable Drugs Production Share by Manufacturers in 2018
Table Global Oncology Generic Injectable Drugs Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Oncology Generic Injectable Drugs Revenue Share by Manufacturers (2014-2019)
Figure Global Oncology Generic Injectable Drugs Revenue Share by Manufacturers in 2018
Table Global Market Oncology Generic Injectable Drugs Average Price (USD/Unit) of Key Manufacturers (2014-2019)
Figure Global Market Oncology Generic Injectable Drugs Average Price (USD/Unit) of Key Manufacturers in 2018
Table Manufacturers Oncology Generic Injectable Drugs Production Sites and Area Served
Table Manufacturers Oncology Generic Injectable Drugs Product Types
Figure Oncology Generic Injectable Drugs Market Share of Top 5 Manufacturers
Figure Oncology Generic Injectable Drugs Market Share of Top 10 Manufacturers
Table Global Oncology Generic Injectable Drugs Production (K Units) by Region (2014-2019)
Table Global Oncology Generic Injectable Drugs Production Market Share by Region (2014-2019)
Figure Global Oncology Generic Injectable Drugs Production Market Share by Region (2014-2019)
Figure Global Oncology Generic Injectable Drugs Production Market Share by Region in 2018
Table Global Oncology Generic Injectable Drugs Revenue (Million USD) by Region (2014-2019)
Table Global Oncology Generic Injectable Drugs Revenue Market Share by Region (2014-2019)
Figure Global Oncology Generic Injectable Drugs Revenue Market Share by Region (2014-2019)
Figure Global Oncology Generic Injectable Drugs Revenue Market Share by Region in 2018
Figure Global Oncology Generic Injectable Drugs Production (K Units) Growth Rate (2014-2019)
Table Global Oncology Generic Injectable Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure North America Oncology Generic Injectable Drugs Production (K Units) Growth Rate (2014-2019)
Table North America Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Europe Oncology Generic Injectable Drugs Production (K Units) Growth Rate (2014-2019)
Table Europe Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure China Oncology Generic Injectable Drugs Production (K Units) Growth Rate (2014-2019)
Table China Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Japan Oncology Generic Injectable Drugs Production (K Units) Growth Rate (2014-2019)
Table Japan Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Global Oncology Generic Injectable Drugs Consumption (K Units) Market by Region (2014-2019)
Table Global Oncology Generic Injectable Drugs Consumption Market Share by Region (2014-2019)
Figure Global Oncology Generic Injectable Drugs Consumption Market Share by Region (2014-2019)
Figure Global Oncology Generic Injectable Drugs Consumption Market Share by Region in 2018
Figure North America Oncology Generic Injectable Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Europe Oncology Generic Injectable Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure China Oncology Generic Injectable Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Japan Oncology Generic Injectable Drugs Consumption Growth Rate (2014-2019) (K Units)
Table Global Oncology Generic Injectable Drugs Production (K Units) by Type (2014-2019)
Table Global Oncology Generic Injectable Drugs Production Share by Type (2014-2019)
Figure Production Market Share of Oncology Generic Injectable Drugs by Type (2014-2019)
Figure Production Market Share of Oncology Generic Injectable Drugs by Type in 2018
Table Global Oncology Generic Injectable Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Oncology Generic Injectable Drugs Revenue Share by Type (2014-2019)
Figure Revenue Share of Oncology Generic Injectable Drugs by Type (2014-2019)
Figure Revenue Market Share of Oncology Generic Injectable Drugs by Type in 2018
Table Global Oncology Generic Injectable Drugs Price (USD/Unit) by Type (2014-2019)
Figure Global Oncology Generic Injectable Drugs Production Growth by Type (2014-2019) (K Units)
Table Global Oncology Generic Injectable Drugs Consumption (K Units) by Application (2014-2019)
Table Global Oncology Generic Injectable Drugs Consumption Market Share by Application (2014-2019)
Figure Global Oncology Generic Injectable Drugs Consumption Market Share by Applications (2014-2019)
Figure Global Oncology Generic Injectable Drugs Consumption Market Share by Application in 2018
Table Global Oncology Generic Injectable Drugs Consumption Growth Rate by Application (2014-2019)
Figure Global Oncology Generic Injectable Drugs Consumption Growth Rate by Application (2014-2019)
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Production Sites and Area Served
Table Teva Pharmaceutical Product Introduction, Application and Specification
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Teva Pharmaceutical Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Figure Teva Pharmaceutical Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Teva Pharmaceutical Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Main Business and Markets Served
Table Pfizer Oncology Generic Injectable Drugs Production Sites and Area Served
Table Pfizer Product Introduction, Application and Specification
Table Pfizer Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pfizer Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Figure Pfizer Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Pfizer Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Pfizer Main Business and Markets Served
Table AstraZeneca Oncology Generic Injectable Drugs Production Sites and Area Served
Table AstraZeneca Product Introduction, Application and Specification
Table AstraZeneca Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure AstraZeneca Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Figure AstraZeneca Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure AstraZeneca Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table AstraZeneca Main Business and Markets Served
Table Roche Oncology Generic Injectable Drugs Production Sites and Area Served
Table Roche Product Introduction, Application and Specification
Table Roche Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Roche Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Figure Roche Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Roche Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Roche Main Business and Markets Served
Table Eli Lilly Oncology Generic Injectable Drugs Production Sites and Area Served
Table Eli Lilly Product Introduction, Application and Specification
Table Eli Lilly Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Eli Lilly Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Figure Eli Lilly Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Eli Lilly Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Eli Lilly Main Business and Markets Served
Table GlaxoSmithKline Oncology Generic Injectable Drugs Production Sites and Area Served
Table GlaxoSmithKline Product Introduction, Application and Specification
Table GlaxoSmithKline Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Figure GlaxoSmithKline Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure GlaxoSmithKline Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table GlaxoSmithKline Main Business and Markets Served
Table Novartis Oncology Generic Injectable Drugs Production Sites and Area Served
Table Novartis Product Introduction, Application and Specification
Table Novartis Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Novartis Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Figure Novartis Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Novartis Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Novartis Main Business and Markets Served
Table Mylan Oncology Generic Injectable Drugs Production Sites and Area Served
Table Mylan Product Introduction, Application and Specification
Table Mylan Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Mylan Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Figure Mylan Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Mylan Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Mylan Main Business and Markets Served
Table Natco Pharma Oncology Generic Injectable Drugs Production Sites and Area Served
Table Natco Pharma Product Introduction, Application and Specification
Table Natco Pharma Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Natco Pharma Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Figure Natco Pharma Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Natco Pharma Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Natco Pharma Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Generic Injectable Drugs
Figure Manufacturing Process Analysis of Oncology Generic Injectable Drugs
Figure Oncology Generic Injectable Drugs Industrial Chain Analysis
Table Oncology Generic Injectable Drugs Distributors List
Table Oncology Generic Injectable Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Oncology Generic Injectable Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Oncology Generic Injectable Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Oncology Generic Injectable Drugs Price and Trend Forecast (2019-2025)
Table Global Oncology Generic Injectable Drugs Production (K Units) Forecast by Region (2019-2025)
Figure Global Oncology Generic Injectable Drugs Production Market Share Forecast by Region (2019-2025)
Figure North America Oncology Generic Injectable Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure North America Oncology Generic Injectable Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Oncology Generic Injectable Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Oncology Generic Injectable Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Oncology Generic Injectable Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure China Oncology Generic Injectable Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Oncology Generic Injectable Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Oncology Generic Injectable Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Oncology Generic Injectable Drugs Consumption (K Units) Forecast by Regions (2019-2025)
Figure Global Oncology Generic Injectable Drugs Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Oncology Generic Injectable Drugs Consumption (K Units) Growth Rate Forecast (2019-2025)
Figure Europe Oncology Generic Injectable Drugs Consumption (K Units) Growth Rate Forecast (2019-2025)
Figure China Oncology Generic Injectable Drugs Consumption (K Units) Growth Rate Forecast (2019-2025)
Figure Japan Oncology Generic Injectable Drugs Consumption (K Units) Growth Rate Forecast (2019-2025)
Table Global Oncology Generic Injectable Drugs Production (K Units) Forecast by Type (2019-2025)
Figure Global Oncology Generic Injectable Drugs Production (K Units) Forecast by Type (2019-2025)
Table Global Oncology Generic Injectable Drugs Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Oncology Generic Injectable Drugs Revenue Market Share Forecast by Type (2019-2025)
Table Global Oncology Generic Injectable Drugs Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Oncology Generic Injectable Drugs Consumption (K Units) Forecast by Application (2019-2025)
Figure Global Oncology Generic Injectable Drugs Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Request Discount 
Inquire Before Buy
